Insights On Pharmaceutical Production

31. What Dosage Form Provides A Release Drug Control Rate? 3/22/2019

    Whether your goal is to increase patient compliance, improve clinical outcomes, or to extend a product’s lifecycle, modified-release dosage forms present a solution to myriad challenges. 

32. Steps Ahead: Planning For Future Equipment Surpluses From The Point Of Procurement 11/28/2018

    Planning and preparation are the keys to success in any enterprise, and making plans for the possibility of equipment liquidation from the time of procurement is no exception. There are clear advantages to planning for your facility’s future, especially if it includes the opportunity for cost savings or a new way to look at purchasing budgets.

33. Mass Transfer Of Single-Use Fermenters To Stirred Glass Bioreactors 9/20/2018

    Performance demands in industrial microbiology have limited conversion of traditional fermentation processes into single-use systems. To address microbial application needs, single-use fermentors are meeting the requirements of microbial fermentation instead of being modified from a cell culture bioreactor.

34. Process Intensification: Getting More From Less 4/24/2019

    Intensifying or simplifying your bioprocess can mean more product, shorter manufacturing times, or lower costs –understanding what matters most is key to making the right decisions.

35. Meeting Regulatory Requirements With A Trusted Equipment Partner 11/28/2018

    Pharmaceutical suppliers are tasked with responding to ever-evolving changes in regulatory requirements, which impact everything within an organization—from operations to the way trials are conducted.

36. Meeting The Changing Demands For Sterile-Fill Finish Operations 10/16/2018

    Meeting the growing demand for fill-finish services requires specialized expertise, appropriate equipment and innovations in both emerging technology and business models.

37. Line Of Sight - Enabling Lyophilization Scale-Up From Formulation To Full Commercial Production 7/29/2020

    Line of Sight suite of freeze-drying equipment with scalable lyophilization technologies and process analytical technology (PAT) tools have been developed to provide the tools for a more successful scale-up of a lyophilization process from formulation through to full commercial production. This ensures superior product quality and uniformity and creates a data rich environment across all sizes of freeze-drying systems.

38. A QbD Approach To Continuous Tablet Manufacture - Utilizing The FT4 Powder Rheometer And The GEA ConsiGma™ Twin Screw High Shear Granulator 3/13/2019

    In order to maximize the benefit of continuous processing, and obtain regulatory approval, it is necessary to establish the link between the processing parameters and the product attributes - something that is difficult to achieve due to the insensitivity of many traditional methods for powder and granule testing. This study summarizes initial work between Freeman Technology and GEA which has explored the relationship between granule properties and variation in formulation and processing parameters in a continuous manufacturing environment.

39. Translating Biopharma Knowledge To Cell And Gene Therapies 5/6/2019

    Streamlining, connecting, and automating workflows to shape the future of cellular treatment delivery has the potential to transform how we treat and potentially cure once life-threatening diseases.

40. Providing Solutions At Fair Value: A Spray Drying Case Study 3/18/2020

    Pharmaceutical companies need CDMO partners that provide solutions at fair value. This CMO has a long history of investing in new technologies with innovators to help their customers achieve their goals, and one recent example is the construction of a new Hastelloy spray-drying unit.